Has Kahlil Saad, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,255 in general payments to Kahlil Saad, MD across 88 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kahlil Saad, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kahlil Saad, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kahlil Saad, MD

Urology · Wichita, KSNPI 1023351905

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 88 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 8.4% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for urology clinicians in KS, where the typical reported total is $2,717.

$2,255in general payments, 2019–2025

Across 88 payments — averaging $25.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Dendreon Pharmaceuticals LLC$189
Merck$174
Bayer$161
Boston Scientific$157
Sumitomo Pharma America, Inc.$144
Johnson & Johnson$142
plus $1K from 24 others

$61,053in research payments, 2019–2025

Across 25 payments — averaging $2442.13 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Sumitomo Pharma America, Inc.$61K

What the payments were for

Food & beverage$2,255100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Dendreon Pharmaceuticals LLC	7	$189
Merck	11	$174
Bayer	6	$161
Boston Scientific	2	$157
Sumitomo Pharma America, Inc.	8	$144
Johnson & Johnson	8	$142
Ferring Pharmaceuticals Inc.	2	$125
Teleflex LLC	5	$106
Myovant Sciences Inc.	1	$93
Progenics Pharmaceuticals, Inc.	2	$88
Verity Pharmaceuticals Inc.	2	$88
Medtronic	1	$79
Clarus Therapeutics Inc.	1	$75
GE HealthCare	1	$59
Alnylam Pharmaceuticals Inc.	3	$57
Urogen Pharma, Inc.	2	$56
Novartis	2	$55
Blue Earth Diagnostics	3	$53
Coloplast	3	$42
Tolmar Pharmaceuticals, Inc.	3	$41
Siemens Medical Solutions USA, Inc.	1	$38
Calyxo, Inc.	2	$34
ABC Home Medical Supply, Inc.	2	$34
Myriad Genetic Laboratories, Inc.	2	$32
Novo Nordisk	2	$32
Urovant Sciences Inc	2	$26
Vertex	1	$25
Travere Therapeutics, Inc.	1	$21
Heron Therapeutics, Inc.	1	$18
Tolmar, Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

AMS$141
FIRMAGON$109

How this compares

$2,255 in reported general payments places this provider in the 45th percentile of 111 urology providers in Kansas.

See all urology providers in Kansas →

Medicare billing

Part B allowed, 2024

$157,503

Medicare patients

542

Services billed

4,563

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Tamsulosin Hcl	28	$322

Paid to pharmacies, not to this prescriber.

Other urology in Wichita

Timothy RichardsonWichita$493K
Gregory ByrdWichita$18K
Philippe NabboutWichita$13K
Fadi JoudiWichita$12K
Ayham FarhaWichita$8K
Jeffrey DavisWichita$8K
James GilbaughWichita$5K
Jonathan JensenWichita$4K
George ZakhariaWichita$3K
Surendra KollaWichita$3K

See the full list for Kansas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →